1. Home
  2. News
  3. Lumos Diagnostics Holdings Ltd.
  4. ViraDx Receives Interim Order Authorisation in Canada
More Lumos Diagnostics Holdings Ltd. news
Lumos Diagnostics Holdings Ltd.ASX: LDX

ViraDx Receives Interim Order Authorisation in Canada

Jun 26, 2022 at 11:19 PM EDT · Issued by Lumos Diagnostics Holdings Ltd.

Filed with ASX · Jun 26, 2022 at 11:19 PM EDT · 3 pages · English

On 6ix: 6ix.com/news/viradx-receives-interim-order-authorisation-in-canada

Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20↗

Lumos Diagnostics Holdings Ltd. on 6ix

Story so far

  • Lumos Receives Initial Orders for CoviDx In CanadaDec 20, 2021
  • LDX received authorization to sell CoviDx in CanadaNov 3, 2021

Earlier from Lumos Diagnostics

  • Security Class Suspension from Quotation LDXOJun 23, 2022
  • Lumos Diagnostics Appoints Doug Ward as CEOJun 21, 2022
  • Lumos secures initial development services contractJun 16, 2022
  • Successful Completion of Institutional Entitlement OfferJun 7, 2022
  • Target Market DeterminationJun 6, 2022

Later from Lumos Diagnostics

  • Security Class Reinstatement of Quotation LDXOJun 30, 2022
  • Voluntary SuspensionJul 7, 2022
  • FDA Decision for FebriDxJul 10, 2022
  • Reinstatement to Official QuotationJul 11, 2022
  • Lumos To Close Sarasota FacilityAug 1, 2022
All Lumos Diagnostics news releases↗

Follow Lumos Diagnostics into a list and get an email when it puts out news.

Follow Lumos Diagnostics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer